Centocor Ortho Biotech Acquires Respivert to Strengthen Pulmonary Focus

News   Jun 14, 2010

 
Centocor Ortho Biotech Acquires Respivert to Strengthen Pulmonary Focus
 
 
 

RELATED ARTICLES

Lonza Expands Encapsulation and HPAPI Capabilities in North America

News

Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.

READ MORE

Shire, Microsoft and EURORDIS Form Global Commission to Accelerate Rare Disease Diagnosis

News

The alliance aims to shorten the often multi-year journey that patients and families endure before being diagnosed with a rare disease.

READ MORE

Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer

News

A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE